Kristin Loening Macarthur, MD | |
1224 Main St, Branford, CT 06405-3778 | |
(203) 481-0315 | |
(203) 481-6788 |
Full Name | Kristin Loening Macarthur |
---|---|
Gender | Female |
Speciality | Gastroenterology |
Experience | 14 Years |
Location | 1224 Main St, Branford, Connecticut |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225357809 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | 055229 (Connecticut) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Yale-new Haven Hospital | New haven, CT | Hospital |
Lawrence & Memorial Hospital | New london, CT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Digestive Disease Associates Llc | 5395644512 | 8 |
Yale University | 9436061736 | 2241 |
News Archive
A new study conducted by researchers at the University of New South Wales has indicated the extent to which adolescents in Australia have been psychologically affected by the coronavirus disease 2019 (COVID-19) pandemic.
Researchers say they have discovered a gene mutation that slows the metabolism of sugar in the gut, giving people who have the mutation a distinct advantage over those who do not.
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies for neurodegenerative diseases, is presenting results from its phase 2a study of NurOwn in amyotrophic lateral sclerosis (ALS) at a poster session today at the American Academy of Neurology annual meeting, taking place in Washington D.C.
HIV-positive patients have a higher incidence of non-melanoma skin cancers, according to a Kaiser Permanente study that appears in the current online issue of the Journal of the National Cancer Institute. Specifically, basal cell and squamous cell carcinomas occur more than twice as often among HIV-positive individuals compared to those who are HIV-negative.
Quick-Med Technologies, Inc., a leader in developing innovative antimicrobial technologies for the healthcare and consumer markets, announced today that the U.S. Patent and Trademark Office has issued a Notice of Allowance for intellectual property that significantly adds to the current patent coverage for the Company's NIMBUS technology.
› Verified 1 days ago
Entity Name | Yale University |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015 |
News Archive
A new study conducted by researchers at the University of New South Wales has indicated the extent to which adolescents in Australia have been psychologically affected by the coronavirus disease 2019 (COVID-19) pandemic.
Researchers say they have discovered a gene mutation that slows the metabolism of sugar in the gut, giving people who have the mutation a distinct advantage over those who do not.
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies for neurodegenerative diseases, is presenting results from its phase 2a study of NurOwn in amyotrophic lateral sclerosis (ALS) at a poster session today at the American Academy of Neurology annual meeting, taking place in Washington D.C.
HIV-positive patients have a higher incidence of non-melanoma skin cancers, according to a Kaiser Permanente study that appears in the current online issue of the Journal of the National Cancer Institute. Specifically, basal cell and squamous cell carcinomas occur more than twice as often among HIV-positive individuals compared to those who are HIV-negative.
Quick-Med Technologies, Inc., a leader in developing innovative antimicrobial technologies for the healthcare and consumer markets, announced today that the U.S. Patent and Trademark Office has issued a Notice of Allowance for intellectual property that significantly adds to the current patent coverage for the Company's NIMBUS technology.
› Verified 1 days ago
Entity Name | Digestive Disease Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1356480578 PECOS PAC ID: 5395644512 Enrollment ID: O20040107000567 |
News Archive
A new study conducted by researchers at the University of New South Wales has indicated the extent to which adolescents in Australia have been psychologically affected by the coronavirus disease 2019 (COVID-19) pandemic.
Researchers say they have discovered a gene mutation that slows the metabolism of sugar in the gut, giving people who have the mutation a distinct advantage over those who do not.
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies for neurodegenerative diseases, is presenting results from its phase 2a study of NurOwn in amyotrophic lateral sclerosis (ALS) at a poster session today at the American Academy of Neurology annual meeting, taking place in Washington D.C.
HIV-positive patients have a higher incidence of non-melanoma skin cancers, according to a Kaiser Permanente study that appears in the current online issue of the Journal of the National Cancer Institute. Specifically, basal cell and squamous cell carcinomas occur more than twice as often among HIV-positive individuals compared to those who are HIV-negative.
Quick-Med Technologies, Inc., a leader in developing innovative antimicrobial technologies for the healthcare and consumer markets, announced today that the U.S. Patent and Trademark Office has issued a Notice of Allowance for intellectual property that significantly adds to the current patent coverage for the Company's NIMBUS technology.
› Verified 1 days ago
Entity Name | Connecticut Gastroenterology Consultants Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669674743 PECOS PAC ID: 3476506353 Enrollment ID: O20050303000109 |
News Archive
A new study conducted by researchers at the University of New South Wales has indicated the extent to which adolescents in Australia have been psychologically affected by the coronavirus disease 2019 (COVID-19) pandemic.
Researchers say they have discovered a gene mutation that slows the metabolism of sugar in the gut, giving people who have the mutation a distinct advantage over those who do not.
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies for neurodegenerative diseases, is presenting results from its phase 2a study of NurOwn in amyotrophic lateral sclerosis (ALS) at a poster session today at the American Academy of Neurology annual meeting, taking place in Washington D.C.
HIV-positive patients have a higher incidence of non-melanoma skin cancers, according to a Kaiser Permanente study that appears in the current online issue of the Journal of the National Cancer Institute. Specifically, basal cell and squamous cell carcinomas occur more than twice as often among HIV-positive individuals compared to those who are HIV-negative.
Quick-Med Technologies, Inc., a leader in developing innovative antimicrobial technologies for the healthcare and consumer markets, announced today that the U.S. Patent and Trademark Office has issued a Notice of Allowance for intellectual property that significantly adds to the current patent coverage for the Company's NIMBUS technology.
› Verified 1 days ago
Entity Name | Digestive Disease Associates Endoscopy Suite Llc |
---|---|
Entity Type | Part B Supplier - Ambulatory Surgical Center |
Entity Identifiers | NPI Number: 1972758183 PECOS PAC ID: 3779630835 Enrollment ID: O20090408000077 |
News Archive
A new study conducted by researchers at the University of New South Wales has indicated the extent to which adolescents in Australia have been psychologically affected by the coronavirus disease 2019 (COVID-19) pandemic.
Researchers say they have discovered a gene mutation that slows the metabolism of sugar in the gut, giving people who have the mutation a distinct advantage over those who do not.
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies for neurodegenerative diseases, is presenting results from its phase 2a study of NurOwn in amyotrophic lateral sclerosis (ALS) at a poster session today at the American Academy of Neurology annual meeting, taking place in Washington D.C.
HIV-positive patients have a higher incidence of non-melanoma skin cancers, according to a Kaiser Permanente study that appears in the current online issue of the Journal of the National Cancer Institute. Specifically, basal cell and squamous cell carcinomas occur more than twice as often among HIV-positive individuals compared to those who are HIV-negative.
Quick-Med Technologies, Inc., a leader in developing innovative antimicrobial technologies for the healthcare and consumer markets, announced today that the U.S. Patent and Trademark Office has issued a Notice of Allowance for intellectual property that significantly adds to the current patent coverage for the Company's NIMBUS technology.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Kristin Loening Macarthur, MD 687 Main St, Branford, CT 06405-3612 Ph: (203) 481-0315 | Kristin Loening Macarthur, MD 1224 Main St, Branford, CT 06405-3778 Ph: (203) 481-0315 |
News Archive
A new study conducted by researchers at the University of New South Wales has indicated the extent to which adolescents in Australia have been psychologically affected by the coronavirus disease 2019 (COVID-19) pandemic.
Researchers say they have discovered a gene mutation that slows the metabolism of sugar in the gut, giving people who have the mutation a distinct advantage over those who do not.
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies for neurodegenerative diseases, is presenting results from its phase 2a study of NurOwn in amyotrophic lateral sclerosis (ALS) at a poster session today at the American Academy of Neurology annual meeting, taking place in Washington D.C.
HIV-positive patients have a higher incidence of non-melanoma skin cancers, according to a Kaiser Permanente study that appears in the current online issue of the Journal of the National Cancer Institute. Specifically, basal cell and squamous cell carcinomas occur more than twice as often among HIV-positive individuals compared to those who are HIV-negative.
Quick-Med Technologies, Inc., a leader in developing innovative antimicrobial technologies for the healthcare and consumer markets, announced today that the U.S. Patent and Trademark Office has issued a Notice of Allowance for intellectual property that significantly adds to the current patent coverage for the Company's NIMBUS technology.
› Verified 1 days ago
Michael W Cleman, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 11 Harrison Ave, Branford, CT 06405 Phone: 203-483-3000 Fax: 203-483-8314 | |
Dr. Richard Sang-wook Rhee, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 500 E Main St, Ste 212, Branford, CT 06405 Phone: 203-481-5665 Fax: 203-481-5524 | |
Belinda Juliet Chan, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 420 E Main St Ste 3, Branford, CT 06405 Phone: 203-481-2280 Fax: 203-481-2275 | |
Mrs. Karen Stemler, APRN Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 960 Main St, Branford, CT 06405 Phone: 203-488-6358 Fax: 203-481-5327 | |
Dr. Michael Phillip Dorfman, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1224 Main St, Branford, CT 06405 Phone: 203-481-0315 | |
Florence Chan, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 960 Main St, Branford, CT 06405 Phone: 203-488-6358 Fax: 203-481-5327 | |
Dr. Jon Michael Fessel, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 420 E Main Street, Building 2 Suite 3, Branford, CT 06405 Phone: 203-488-2100 Fax: 203-488-7400 |